An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the companies announced Wednesday. The positive results mean a potentially life-extending treatment is one step closer to being available on the market. They also herald a significant and…
Politics
·
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Mike Turner calls for investigation into Ukraine’s loss of Starlink access
Rep. Mike Turner (R-Ohio) called for an investigation into Ukrainian forces losing access to a military version of Starl...
CitrixNews Staff
·
39 minutes ago
Politics
Mass. GOP candidate for Lt. Gov. suspends campaign after arrest, OUI charge
Shawn Oliver, the running mate of Massachusetts Republican gubernatorial candidate Mike Minogue, suspended his campaign ...
CitrixNews Staff
·
46 minutes ago
Politics
Israeli filmmakers bring counter ‘NAZA’ programming to Capitol Hill
At least one attendee at a recent Capitol Hill screening for a film called “NAZA” was hoodwinked into believing it was a...
CitrixNews Staff
·
1 hour ago
Politics
Elizabeth Holmes documentary draws 2,000 sold-out shows in limited release
Comedian and satirist Nathan Fielder’s documentary about Elizabeth Holmes drew 2,000 sold-out shows in its limited relea...
CitrixNews Staff
·
1 hour ago